Assertio (ASRT) Earnings Call Presentation

Financial Performance & Outlook - The company's Q1 2025 net product sales were $26 million[27] - The company's Q1 2025 non-GAAP adjusted EBITDA was $02 million[27] - The company's Q1 2025 operating cash flow was -$125 million[27] - The company anticipates full-year 2025 net product sales of $108-123 million[27] - The company anticipates full-year 2025 non-GAAP adjusted EBITDA of $10-19 million[27] Strategic Priorities - The company is focused on a "Transformation" phase to catalyze future growth potential[28, 29] - The company aims to simplify its corporate structure and processes[28, 29, 36] - The company intends to divest declining or non-core assets[28, 29, 36] - The company will prioritize investment in growth assets like Rolvedon and Sympazan[28, 29, 36] - The company seeks to reduce legal exposure[28, 29, 36] - The company plans to use its balance sheet to close a strategic transaction[28, 29, 36]